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Background  and  purpose:  Data  regarding  electrocardiographic  characteristics  of  postmenopausal  women
are lacking.  In this  prospective,  cross-sectional  study,  electrocardiographic  P-wave  parameters  and  car-
diac  repolarization  indices  of  age-matched  pre-  and  postmenopausal  healthy  women  were  compared.
We  hypothesized  that  menopausal  status  would  have  a signiﬁcant  effect  on  cardiac  electrical  activity  and
hence electrocardiography  (ECG)  recordings.
Materials and  methods:  Twelve-lead  ECG  recordings  were  obtained  from  125  consecutively  recruited
postmenopausal  healthy  women  aged  between  44  and 54  years.  The  control  group  consisted  of  125 age-
matched  premenopausal  women.  P-wave  parameters  and  cardiac  repolarization  indices  were  measured
and compared  with  respect  to menopausal  status.
Results:  Demographic  features  of premenopausal  and  postmenopausal  women  were comparable.  There
were  no  signiﬁcant  differences  between  two  groups  regarding  mean  values  of heart rate,  maximum  and
minimum  P-wave  duration,  P-wave  dispersion,  maximum  and  minimum  QT interval,  and  QT  dispersion.
Mean  values  of  QT  interval  obtained  from  lead  V5  were  also similar.  Corrected  values  which  were  cal-
culated  according  to Bazett and  Fridericia  formulas  also  did  not  differ  between  the  groups.  Mean  values
of Tpeak  to Tend  (TpTe)  (p < 0.001)  and  corrected  TpTe  (p  =  0.001)  intervals  obtained  from  lead  V5  were
signiﬁcantly  shorter  in  postmenopausal  women  when  compared  to those  without  menopause.
Conclusion:  Tpeak  to Tend  interval  decreased  signiﬁcantly  while  QT intervals  and  P-wave  parameters  did
not change  in  postmenopausal  women  when  compared  to premenopausal  women.  Association  of these
ﬁndings  with  changes  in levels  of  sex  steroids  and  their  prognostic  implications  need to  be  elucidated
with  further  studies.
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The risk of cardiovascular disease increases signiﬁcantly in the
ostmenopausal period. The relative delay in onset of cardiovascu-
ar and arrhythmic events in females compared to males gradually
ecreases over time particularly in menopausal years [1,2].
ndogenous estrogen levels decrease signiﬁcantly in menopause.
onﬂicting data regarding the association between hypoestrogenic
tate and cardiovascular disease make it difﬁcult to attribute all the
dverse outcomes to a single mechanism. In this regard, the physio-
ogical properties of the cardiac conduction system in women  have
roused considerable interest. Electrocardiographic characteristics
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with respect to menopausal status have been studied extensively
in women  with known cardiovascular disease [3,4]. As far as we
know there are no data about the effects of menopausal status on
electrocardiographic parameters in healthy women.
In this prospective, cross-sectional study we  compared P-wave
parameters and cardiac repolarization indices in 12-lead elec-
trocardiography (ECG) recordings of age-matched pre- and post-
menopausal healthy women. We  hypothesized that menopausal
status would have a signiﬁcant effect on cardiac electrical activity
and hence ECG recordings.
Materials and methods
This prospective study was carried out between July and
December 2011 in the Cardiology Department of Meram School
of Medicine and the Obstetrics and Gynecology Department of
Selcuklu School of Medicine, Selcuk University, Konya Turkey
with the approval of the Institutional Ethics Committee. Informed
vier Ltd. All rights reserved.
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Table 1
Demographic characteristics of pre- and postmenopausal women.
Premenopausal
(n = 125)
Postmenopausal
(n = 125)
p
Age (years) 48 ± 3 48 ± 3 0.5934 U. Dogan et al. / Journal o
onsent was obtained from all participants. A total of 125 consec-
tively recruited postmenopausal women aged between 44 and
4 years were included in the study. Menopausal status was deﬁned
s cessation of menses for more than one year. In previous stud-
es, age was an independent factor for changes in ECG parameters
nd for this reason 125 age-matched premenopausal women  con-
tituted the control group [5]. Women  with surgical menopause
ere excluded. Women  admitted for any benign gynecologic prob-
em were included but patients with any suspected or diagnosed
enital malignancy were excluded. Pregnant women, recent users
f oral contraceptives and women on any hormone replacement
herapy were also excluded. Other exclusion criteria were history
r clinical suspicion of ischemic or structural heart disease, any
ind of arrhythmia, conduction defect or antiarrhythmic drug use
r history of hypertension, diabetes mellitus, smoking, and drug
buse.
nalyses of ECG parameters
ECG recordings of premenopausal women were performed in
arly follicular phase, second or third day of the menstruation in
rder to avoid the excessive effects of estrogen. ECGs were recorded
t a paper speed of 50 mm/s  and a calibration of 1 mV  = 20 mm  and
canned to digital media in 300 dpi. Then they were transferred
o high-resolution computer screens and evaluated by one of the
nvestigators (A.O.B) who was blinded to clinical and patient infor-
ation.
easurement of P-wave parameters and cardiac repolarization
ndices
Three consecutive beats were used for analysis and at least 10
eads were analyzable in all ECGs. P-wave duration was deﬁned
s the time measured from the onset to the end of the P-wave
eﬂection. The onset of the P-wave was considered as the junc-
ion between isoelectric line and ﬁrst visible upward or downward
lope of the trace. The return of the trace to the isoelectric line was
onsidered to be the end of the P-wave. P-wave dispersion (Pd) was
eﬁned as the difference between maximum and minimum P-wave
urations (Pmax and Pmin, respectively) occurring in any of the 12
eads [6].
QT interval was deﬁned as the interval from the beginning of
he QRS complex to the end of the T wave. The end of the T wave
as deﬁned as intersection of the terminal limb of the T wave
ith the isoelectric baseline [7].  The longest and the shortest QT
ntervals across 12 leads were deﬁned as the maximum QT (QTmax)
nd the minimum QT (QTmin) intervals, respectively. They were
orrected according to heart rate by using the Bazett formula and
eﬁned as corrected QTmax (QTmaxc) and corrected QTmin (QTminc),
espectively [8].  QTc dispersion (QTcd) was deﬁned as the differ-
nce between QTmaxc and QTminc. Bazett formula was  preferred to
rovide uniformity and enable comparison with other studies [9].
egarding previous published data reporting probable signiﬁcant
rrors using a single correction formula [10,11], Fridericia formula
as also used since it was suggested as a successful method for rate-
djustment in middle-aged populations [12]. Intervals between
wo consecutive R-waves were deﬁned as RR interval.
azett : QTc =
QT
(RR)1/2
QT
ridericia : QTc =
(RR)1/3
or the Tpeak to Tend interval (TpTe) measurement, time interval
etween peak of T wave, i.e. the time point in which T wave hadBody  mass index (kg/m2) 28 ± 5 29 ± 5 0.28
Time  from menopause (years) – 3 ± 2 –
highest amplitude and end of T wave which also was  deﬁned as
the crossing point of T wave and isoelectric line was noted as a
function of time. TpTe was also corrected according to heart rate
and referred as TpTec. Abnormal ECG recordings with ambiguous T
or P-waves, distorted, ﬂat or with high noise levels by any means
were excluded.
To determine the intraobserver variability, measurements of 30
randomly selected cases were repeated by the investigator. Agree-
ment between measurements of QT and TpTe intervals obtained
from lead V5 and Pmax were assessed using the Bland–Altman
method [13]. Furthermore, intraclass correlation coefﬁcients were
calculated to assess reliability. The 95% limits of intraobserver
agreement for QT interval were −11.5 and 23.5 milliseconds (ms),
which means that there was  a 95% probability that the repeated
measurements differed no more than 11.5–23.5 ms  from the ﬁrst
measurement. The 95% limits of intraobserver agreement for TpTe
were −5.4 and 9.6 ms  and for Pmax were −8.9 and 12.1 ms.  Intraclass
correlation coefﬁcients for QT, TpTe, and Pmax were 0.97, 0.95, and
0.89, respectively. To determine the interobserver variability the
same ECGs were analyzed by another investigator (S.Y.) who was
blinded to clinical and patient information. The 95% limits of inter-
observer agreement for QT interval were −14.2 and 28.9 ms,  for
TpTe were −5.2 and 11.4 ms,  and for Pmax were −8.7 and 14.1 ms,
respectively. Intraclass correlation coefﬁcients for QT,  TpTe, and
Pmax were 0.95, 0.93, and 0.89, respectively.
Statistical analysis
Continuous variables were expressed as mean ± standard devi-
ation and categorical variables as numbers and percentages.
Signiﬁcances of the differences between the groups were tested
by the two-sided independent samples t-test. A p-value less than
0.05 was  considered to be statistically signiﬁcant. Data were ana-
lyzed by using SPSS for Windows version 15.0 (SPSS Inc., Chicago,
IL, USA).
Results
Demographic features of premenopausal and postmenopausal
women were comparable (Table 1). There were no signiﬁcant dif-
ferences between the two  groups regarding heart rate, P-wave
parameters, QTmax, QTmin, and QTd (Table 2). Mean values of QT
interval obtained from V5 were also similar. Mean values of TpTe
(p < 0.001) and TpTec (p = 0.001) intervals obtained from V5 were
signiﬁcantly shorter in postmenopausal women when compared
to those without menopause.
Transthoracic echocardiography was  available in 32 (26%)
of premenopausal and in 39 (31%) of postmenopausal women.
Echocardiographic parameters were comparable between the
groups (Table 3). None of the patients had structural or valvular
heart disease in echocardiographic evaluation. Subgroup analy-
sis of the patients with available echocardiographic data revealed
that TpTe and TpTe intervals were signiﬁcantly shorter in post-c
menopausal women. Other electrocardiographic parameters did
not differ signiﬁcantly (Table 4). Our ﬁndings were similar when
QT and TpTe values were corrected according to the Fridericia
U. Dogan et al. / Journal of Cardi
Table  2
Electrocardiographic parameters of pre- and postmenopausal women.
Premenopausal
(n = 125)
Postmenopausal
(n = 125)
p
Heart rate (bpm) 81 ± 15 82 ± 15 0.54
RR  interval (msc) 767 ± 140 753 ± 127 0.41
Pmax 119 ± 10 120 ± 9 0.37
Pmin 88 ± 12 90 ± 12 0.17
Pd 31 ± 10 30 ± 12 0.61
QT  (V5) 366 ± 36 362 ± 38 0.41
QTc (V5) 420 ± 28 419 ± 32 0.79
QTmax 376 ± 34 372 ± 38 0.44
QTmaxc 432 ± 29 431 ± 34 0.84
QTmin 345 ± 34 339 ± 33 0.20
QTminc 395 ± 25 393 ± 27 0.46
QTd 32 ± 18 33 ± 15 0.59
QTcd 37 ± 22 39 ± 18 0.51
TpTe (V5) 90 ± 10 85 ± 9 <0.001
TpTec (V5) 104 ± 14 98 ± 13 0.001
Bpm, beat per minute; Pmax, maximum P-wave duration; Pmin, minimum P-wave
duration; Pd, P-wave dispersion; QTc, corrected QT interval; QTcd, corrected QT
dispersion; QTd, QT dispersion; QTmax, maximum QT interval; QTmaxc, corrected
maximum QT interval; QTmin, minimum QT interval; QTminc, corrected minimum
QT  interval; TpTe, Tpeak to Tend interval; TpTec, corrected Tpeak to Tend interval.
Table 3
Comparison of the echocardiographic parameters of the patients in which data were
available.
Premenopausal (n = 32) Postmenopausal (n = 39) p
LVEDD (mm) 46 ± 3 46 ± 4 0.73
LVESD (mm)  28 ± 3 28 ± 4 0.50
LV  EF (%) 61 ± 4 61 ± 4 0.80
IVSD (mm) 10 ± 1 10 ± 1.2 0.63
PWD  (mm) 10 ± 1 10 ± 1.2 0.25
LAD  (mm) 33  ± 8 33 ± 5 0.72
IVSD, interventricular septum diameter; LAD, left atrial diameter; LV EF, left ven-
tricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LVESD, left
ventricular end-systolic diameter; PWD, posterior wall diameter.
Table 4
Subgroup analysis of the electrocardiographic parameters in patients in which
echocardiographic data were available.
Premenopausal (n = 32) Postmenopausal (n = 39) p
Heart rate (bpm) 79 ± 11 80 ± 14 0.62
RR  interval (msc) 776 ± 111 770 ± 132 0.83
Pmax 122 ± 10 121 ± 8 0.87
Pmin 88 ± 13 92 ± 11 0.15
Pd 34 ± 11 29 ± 13 0.13
QT  (V5) 372 ± 33 374 ± 39 0.80
QTc (V5) 424 ± 27 429 ± 34 0.49
QTmax 382 ± 31 380 ± 41 0.82
QTmaxc 435 ± 28 435 ± 34 0.99
QTmin 347 ± 28 350 ± 34 0.70
QTminc 395 ± 22 401 ± 26 0.33
QTd 35 ± 16 30 ± 15 0.19
QTcd 40 ± 20 35 ± 16 0.20
TpTe (V5) 88 ± 9 83 ± 6 0.006
TpTec (V5) 101 ± 11 95 ± 12 0.04
bpm, beats per minute; Pmax, maximum P-wave duration; Pmin, minimum P-wave
duration; Pd, P-wave dispersion; QTc, corrected QT interval; QTcd, corrected QT
d
m
Q
f
w
D
oispersion; QTd, QT dispersion; QTmax, maximum QT interval; QTmaxc, corrected
aximum QT interval; QTmin, minimum QT interval; QTminc, corrected minimum
T  interval; TpTe, Tpeak to Tend interval; TpTec, corrected Tpeak to Tend interval.
ormula. To avoid redundancy, only the Bazett-corrected values
ere demonstrated.iscussion
Previous reports studied ECG parameters in different subgroups
f postmenopausal women such as hypertensives, patients withology 60 (2012) 333–337 335
a cardiovascular disease or history of speciﬁc syndromes such as
Brugada syndrome [3,14].  However, as far as we know our study
is the ﬁrst report assessing ECG parameters with respect to
menopausal status in healthy women. Our main ﬁnding was  shorter
TpTe measurements in favor of postmenopausal women. In con-
trary, P-wave parameters and QT intervals were similar between
pre- and postmenopausal women.
QT interval was studied extensively in premenopausal period,
previously. Nakagawa et al. reported that QT intervals ﬂuctuated
within normal limits during menstrual cycle and this ﬂuctuation
was in parallel with changes in levels of sex hormones [15]. Also
postmenopausal hormone replacement, particularly estrogen ther-
apy was shown to increase QT interval [16]. But the exact role of sex
steroids on cardiac conduction system and mechanisms of arrhyth-
mia  are still unclear. Aging reduces cardiac innervation intensity
and causes increased repolarization time [17]. In our study popu-
lation, QT interval did not differ with respect to menopausal status.
Our study group consisted of age-matched women. Hence, aging
but not menopausal status may  be the indicator of QT interval.
TpTe interval which could be readily assessed with surface ECG
is suggested to be a measure of transmural repolarization het-
erogeneity [18]. Longer TpTe measurements were associated with
adverse outcomes in several studies. It has been associated with
increased risk of mortality in individuals with long-QT syndromes,
in cardiomyopathies, and in patients undergoing primary percu-
taneous interventions for myocardial infarction [19–21].  But still,
this issue is controversial and there are clinical data expressing
contradictory results. In a recent study of Smetana et al., car-
diac repolarization indices of over 800 males were assessed and
these patients were followed for up to 14 years prospectively. QT
intervals (both corrected and uncorrected) were longer in patients
who died during follow-up than in survivors, but not statistically
signiﬁcant. Interestingly TpTe intervals were signiﬁcantly longer
in survivors compared with nonsurvivors. Patients with a TpTec
interval above the median (104 ms)  revealed signiﬁcantly better
survival rates as compared with patients with shorter TpTec [22].
Also Korantzopoulos et al. assessed TpTe intervals in 119 females
and males with known coronary artery disease history. Women
subjects had lower TpTe interval measurements, but QTc intervals
were comparable in both sexes [23]. In a popular and highly cited
work by Yan et al., an experimental model of arterially perfused
canine left ventricular wedge preparation showed that peak of the
T wave reﬂects full repolarization of epicardium, whereas the end
of the T wave reﬂects full repolarization of the M region. As a result
the difference (TpTe interval) reﬂects the transwedge dispersion
of action potential duration [18]. In our study, shorter TpTe val-
ues were observed in favor of postmenopausal women  along with
similar QT intervals. These ﬁndings might be explained by prolon-
gation of action potential duration in epicardial region (which is
indicated by Tp) despite no change in action potential duration in
M cell region (which is indicated by Te) in postmenopausal women.
But the ﬁndings of the experimental model of Yan et al. cannot
be directly extrapolated to clinical practice and cannot always be
applicable. Hence shortening of TpTe in postmenopausal women in
our study might reﬂect a physiologic change rather than a disease
state and could not be assumed for increased risk for cardiovascular
diseases. Long-term follow-up studies in this group of women are
warranted to elicit clinical implications of shortened TpTe.
Cardiovascular disease risk increases in the postmenopausal
period when compared to premenopausal years [1,24]. Having
probable electrophysiological effects on myocardium [25], endoge-
nous estrogens might be the key factor providing a protective
effect on the cardiovascular system. However, their exact role on
cardiovascular disease risk is controversial. A number of studies
reported that there was no association between estrogen levels and
cardiovascular diseases [26,27]. In a clinical study with relatively
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mall number of patients, premenopausal women with history
f cardiovascular disease had higher plasma estrodiol levels than
ge-matched healthy premenopausal women without any cardio-
ascular disease [28]. Moreover, data regarding effects of hormone
eplacement in postmenopausal period on cardiovascular system
re also conﬂicting. Previous observational studies revealed a pro-
ective effect [29]. On the contrary, randomized trials demonstrated
ven increased cardiovascular risk in case of hormone replacement
or the postmenopausal period [30,31].
Menopause is the period in a woman’s life in which ovarian folli-
les deplete resulting in low estrogen milieu. Levels of testosterone
lso decrease with respect to premenopausal years [32]. In their
tudy evaluating effects of testosterone on electrocardiographic
epolarization, Kirilmaz et al. reported that in hypogonadotropic
ales with low testosterone levels, ascending and descending
imes of T wave were lower than in healthy eugonagotropic males,
ut QT intervals were similar between the two groups. They specu-
ated that testosterone had no effect on repolarization time, but
t had increased dispersion of repolarization transmurally [33].
ikewise, in our study, shortening of TpTe, the same manner as
ecreased T wave descending time, could reﬂect inﬂuence of low
strogenic and also relatively decreased levels of testosterone in the
ostmenopausal period. Moreover, there are several experimental
tudies suggesting a signiﬁcant role of testosterone in modulat-
ng cardiac repolarization [34]. In oophorectomized female rabbits,
he risk of drug-induced prolongation of action potential duration
nd early afterdepolarization (EAD) were all reduced [35]. Also in
rchidectomized male rabbits testosterone had a protective role
gainst drug-induced excessive prolongation of repolarization and
igh incidence of EAD [36]. The exact role of this phenomenon is
nclear and probably includes complex mechanisms. In a study by
enatar, ECGs of 400 healthy children with respect to TpTe mea-
urements were analyzed. TpTe measurement was higher in older
hildren but was not different in male and female subjects. Most
f the children in this study were prepubertal and free of inﬂuence
f sex steroids [37]. Similar TpTe measurements in two genders
ould be due to prepubertal status reﬂecting possible effect of sex
teroids on electrical activity of the heart.
Increased P-wave duration and Pd are regarded as noninva-
ive electrocardiographic markers which reﬂect the prolongation
f intraatrial and interatrial conduction and inhomogeneous prop-
gation of sinus impulses, respectively [38]. Conduction properties
f the atrium are reported to play an important role in the initiation
nd maintenance of atrial ﬁbrillation [39]. It is well-established that
ugmented P-wave duration and Pd are both independent mark-
rs of future atrial ﬁbrillation [6,40].  Compared to premenopausal
omen, atrial ﬁbrillation incidence is higher in postmenopausal
omen [41]. However, as far as we know, there are no data show-
ng that atrial ﬁbrillation prevalence is higher in postmenopausal
omen than age-matched premenopausal women. In our study,
e aimed to examine whether the changes in P-wave parame-
ers were associated with menopausal state regardless of age. In
 study by Karabag, ECG recordings of 112 women were evalu-
ted in different phases of menstrual cycle. Pd measurements were
igher in luteal phase when compared to follicular phase. There
as a signiﬁcant correlation between the day of menstrual cycle
nd Pd. But no correlation existed between age, estrogen, pro-
esterone levels, and Pd measurements [42]. In an experimental
tudy, 17beta-estradiol was administered to dogs and atrial pac-
ng of 800 min−1 was performed and effective refractory periods
ERP) were evaluated. There was a decrease in atrial ERP with atrial
acing and this effect was more pronounced in animals pretreated
ith 17beta-estradiol [43]. In these two studies, estrogen was  sug-
ested to be a factor inﬂuencing Pd and atrial conduction system.
n contrast, we could not detect a difference either in Pd measure-
ents or P-wave durations with respect to menopausal status. Inology 60 (2012) 333–337
women, aging rather than menopausal status might be the main
determinant of electrophysiologic substrate underlying the devel-
opment of atrial ﬁbrillation. Besides estrogen and aging, there
might be other factors associated with Pd and atrial conduction
system. Recently, Mann et al. reported that the presence of genetic
variants in potassium channels which play a central role in atrial
repolarization might contribute to an arrhythmogenic atrial sub-
strate and lead to increased atrial ﬁbrillation susceptibility [44].
Favorable effects of spironolactone on atrial conduction, remod-
eling and reduction in the burden of atrial ﬁbrillation might be
associated with prolongation of cardiac action potential via block-
ade of potassium channels [45–47].  P-wave duration and dispersion
are parameters mainly associated with depolarization phase of
atria. Atrial repolarization is invisible in the normal ECG and can
be measured by evaluation of the cellular atrial electrophysiol-
ogy. Hence, evaluation of changes in atrial repolarization properties
in postmenopausal women  is beyond the scope of this paper and
needs to be examined in detail in future research.
One of the shortcomings of our study is the lack of follow up
so as to see whether ECG ﬁndings correlate with clinical outcomes.
Clinical correlations of alterations in TpTe and QT intervals were
studied extensively in diseased states as mentioned above. But
our aim was to determine if any difference existed between pre-
and postmenopausal women. To our knowledge this report is the
ﬁrst study assessing ECG parameters with respect to menopausal
status. Age is an important factor which is known to alter ECG
changes. Thus inﬂuence of age was controlled and eliminated by
age matching. Another point is that, the presence of coronary
artery disease was  not excluded with noninvasive stress tests,
since the participants were asymptomatic. Therefore effect of silent
myocardial ischemia on cardiac repolarization indices could not be
completely eliminated. Echocardiographic data were available in
only 28% of the patients. To reduce the effect of this major draw-
back we  performed a subgroup analysis in patients with available
echocardiographic data. Subgroup analysis revealed similar ﬁnd-
ings in patients in which structural heart disease was completely
ruled out by echocardiography. Data regarding blood chemistry and
serum electrolyte levels which might be affected by estrogen were
not available. Moreover, we could not measure testosterone lev-
els because shortening of TpTe was an unexpected ﬁnding in our
study. This might be the subject of future studies. Measurements of
ECG parameters were performed by transferring ECG paper record-
ings to scanner and then to digital media instead of automated or
computer-assisted techniques. But there are a number of studies,
including very recent ones, reporting that manual, automated and
computer-assisted methods for QT measurement are comparable
[48–50]. Current guidelines do not deﬁnitely recommend one of
these methods speciﬁcally until the validation of the use of fully
automated technologies [51,52].  It is not possible to completely
rule out the possibility of measurement errors. But, a high degree of
intra- and interobserver agreement represented by intraclass cor-
relation coefﬁcients and Bland–Altman analysis indicated that our
measurement technique was reproducible.
In conclusion, TpTe decreased signiﬁcantly while QT  intervals
and P-wave parameters did not change in postmenopausal women
when compared to premenopausal women. Association of these
ﬁndings with changes in levels of sex steroids and their prognostic
implications need to be elucidated with further studies.
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